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Objectives: This study aims to develop and validate a country specific osteoporosis risk assessing tool for
Sri Lankan postmenopausal women.
Methods: Community-dwelling postmenopausal women were enrolled to development (n ¼ 602) and
validation (n ¼ 339) samples. Clinical risk factors (CRFs) of osteoporosis were assessed. Bone mineral
densities (BMD) of femoral neck, total hip and lumbar spine were assessed by dual energy X-ray ab-
sorptiometry (DXA) scan. Radial ultrasound (US) bone scan was done. Linear regression analysis was
performed in development sample considering regional BMDs as dependent and CRFs as independent
variables. Regression equations were developed to estimate regional BMDs using best predictive CRFs.
Sensitivity, specificity, positive and negative predictive values (PPV and NPV) were assessed to validate
the new tools.
Results: Age, body weight and US T-scores showed positive correlations with BMDs of all 3 sites. Two
osteoporosis risk assessing tools (OPRATs) were developed as OPRAT-1 and OPRAT-2. Prevalence of
osteoporosis, in the validation sample was 74.3%. Sensitivity were high in both tools (OPRAT-1 and
OPRAT-2; 83.2% and 82.5%) while specificity were moderate (44.8% for both). PPV of OPRAT-1 and OPRAT-
2 were 79.5% and 81.2%. Both tools showed moderate NPV (OPRAT-1 and OPRAT-2; 51% and 47%).
Conclusions: Both OPRAT-1 and OPRAT-2 have high performance in screening postmenopausal women in
Sri Lanka for risk of osteoporosis. OPRAT-2 is more convenient and can be used in any healthcare setting
with limited resources to identify women who will be benefitted by DXA. OPRAT-1 can be used if the
radial US facility is available.
© 2020 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Osteoporosis is an emerging public health concern all over the
world mainly affecting the aging population. The current global
prevalence of osteoporosis is over 200 million [1,2]. In Sri Lanka
approximately 45% of women over 50 years are likely to have
osteoporosis [3]. Fragility fracture is the clinical outcome of oste-
oporosis and hip fracture, the most sinister complication of the
disease, is linked with increased mortality, morbidity, and health
care cost [4e6].ha, Nupe Matara, Sri Lanka.
(H.W.A.S. Subasinghe).
ociety of Osteoporosis.
osis. Publishing services by ElsevAlthough the diagnosis of osteoporosis is based on bonemineral
density (BMD), the restricted availability of the technology limits its
use as a screening tool, especially in resource limited countries.
Osteoporosis risk assessing tools which are based on clinical in-
formation are being used as an alternative to screen patients for
osteoporosis or high fracture risk.
Risk calculators such as Osteoporosis Self-Assessment Tool for
Asians (OSTA), Osteoporosis Risk Assessment Instrument (ORAI),
and Simple Calculated Osteoporosis Risk Estimation (SCORE) are
simple devices validated for local populations [7e12]. They areier B.V. This is an open access article under the CC BY-NC-ND license (http://
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weightage according to the importance. These tools vary with
regards to the sensitivity and specificity in identifying high risk
patients and performance [9,10,13e15].
Osteoporosis risk assessment tools need to be country specific
since the associations between CRFs and osteoporosis or fracture
risk have geographical variation. Many countries have developed
their own models using either own data or data from surrogate
populations. The Korean Osteoporosis Risk-Assessment Model
(KORAM) has been developed specifically for Korean post-
menopausal women and it has 84.8% sensitivity and 51.6% speci-
ficity in identifying high risk postmenopausal women [11].
Furthermore, Osteoporosis Pre-screening Model for Iranian Post-
menopausal women (OPMIP) demonstrates sensitivity and speci-
ficity of 73.2% and 61%, respectively, in detecting high risk
postmenopausal women [16].
In Sri Lanka, DXA facility is restricted to a few major cities
covering only a small proportion of country’s population. Further-
more, no validated methods are available to detect osteoporosis or
high fracture risk. In this study, we aim to fill this lacuna by
developing and validating a country specific osteoporosis risk
assessing tool for Sri Lankan postmenopausal women.
2. Methods
2.1. Participants
Community dwelling post-menopausal women (n ¼ 605) were
selected from Galle district, Sri Lanka by a stratified random sam-
pling method. After initial screening, 602 postmenopausal women
were included in the study sample that was used to develop the tool.
Women who were cognitively impaired, failed to give consent, had
diseases that can affect bone health (malabsorption, hyperparathy-
roidism, hyperthyroidism, hypogonadism) or were on medications
that could affect bone metabolism (thyroxin, thiazide) were
excluded.
The tools developed were validated on a separate sample of
postmenopausal women selected from the same locality using the
same inclusion criteria 6 months after the initial study. Among 364
women, 25 were excluded (cognitively impaired or failed to give
consent) and the final validation sample included 339 post-
menopausal women.
The study was approved by the Ethical Review Committee, Fac-
ulty of Medicine, University of Ruhuna, Sri Lanka (Ref No. March 09,
2016:3.3) and followed the Declaration of Helsinki. All patients
agreed to participate in the study and provided written informed
consent.
2.2. Measurements
A survey of CRFs was conducted using a pre-designed and
content validated data sheet. This survey included details about
demographic and anthropometric data, reproductive history,
medical history and co-morbid conditions, personal and family
history of osteoporotic fractures, behavioral factors such as smok-
ing, alcohol consumption, and glucocorticoids use.
Weight and height were measured adhering to standard pro-
tocols. BMDs of the lumbar spine (L1-L4), femoral neck (FN), and
total hip (Hip) weremeasuredwith DXA scan (Hologic DiscoveryW,
Hologic Inc, Bedford, MA, USA). Women were categorized as oste-
oporosis, osteopenia or normal, based on the BMD T-scores
adhering to the World Health Organization (WHO) criteria [17,18].
Quantitative ultrasound (QUS) (Sunlight Mini Omni, Israel) of the
radius of the non-dominant side was performed in randomly
selected 260 participants of tool development sample and 207123participants of tool validation sample. QUS measures the quality of
bones as speed of sound (SOS, m/s) penetration. SOS data and SOS
associated T-scores were gathered from patients who underwent
QUS scans. All DXA and QUS scans were done by 2 trained tech-
nicians adhering to the manufacturers’ protocols. The machines
were calibrated on each day prior to scanning.
2.3. Statistical analysis
A woman was considered to have osteoporosis if the T-score of
the lumbar spine (L1-L4), femoral neck or total hip region was
 2.5. Descriptive statistics; means (SD) and medians (IQR) were
calculated for continuous numerical variables. Frequency distribu-
tions and percentages were used for categorical variables.
In the tool development process Pearson’s correlation was used
to identify clinical risk factors associated with T-scores. These fac-
tors were used in multilinear regression models (MLR) as inde-
pendent variables and T-scores as dependent variables to assess the
osteoporosis predicting ability. It was aimed to predict regional T-
scores than BMD since absolute BMD is not used in the detection of
osteoporosis. Separate regression analyses were conducted with
and without QUS T-scores. Regression equation to predict regional
T-scoreswas developed bymultiplying each predictor variablewith
its relevant unstandardized coefficient (B) and adding them to the
constant of the model. The best model to predict regional T-scores
was selected based on R2 (coefficient of determinations) which
assessed the predictive ability of the model.
In the validation of the tools, T-scores of hip, FN, and spine were
estimated for all participants in the validation sample using the
osteoporosis risk assessing tools developed above. Actual T-scores
of the spine, hip, and FN were compared with the respective esti-
mated values using the paired t-test. Bland-Altman plots were
constructed to assess the systematic difference between estimated
and actual T-scores. Adhering to the WHO recommendations, the
diagnosis of osteoporosis was made when the T-score was less or
equal 2.5 in the total spine, total hip or femoral neck. The sensi-
tivity, specificity, PPV and NPV of new osteoporosis risk assessment
tools with regards to their ability to discriminate women with and
without osteoporosis were calculated.
The OSTA index was calculated for all study participants in the
validation sample. They were categorized in to high (<4), inter-
mediate (4 to 1), and low risk (>1) groups [7]. The new tools
were compared with the OSTA index.
3. Results
3.1. Characteristics of the development and validation samples
The development and validation samples contained 602 and
339 community dwelling postmenopausal women, respectively.
Table 1 shows the descriptive characteristics of these samples.
The prevalence of osteoporosis in the development sample was
65.3% and another 28.5% had osteopenia. Further, 74.3% women in
the validation sample had osteoporosis while another 21.5% had
osteopenia.
3.2. Development of the tools
In bivariate analysis, anthropometric variables and QUS mea-
sures were associated (P < 0.001) with BMD and BMD based T-
scores of hip, femoral neck, and spine (Table 2). Number of par-
ticipants with parental history of hip fractures, long-term gluco-
corticoid use, previous history of fractures (after 45 years age),
smoking or consumption of alcohol were very lowand did not show
significant associations with BMD or regional T-scores.
Table 1
Descriptive characteristics of development and validation samples.
Variable Development sample Validation sample
Mean (SD)/N (%) Range Mean (SD)/N (%) Range
Age, yr 67.3 (8.3) 43e89 63.8 (9.3) 40e87
Body weight, kg 53.8 (10.1) 27e84 51.8 (10.4) 24e86
Height, cm 148.5 (6.3) 129.0e172.0 147.8 (5.6) 130.0e163.0
BMI, kg/m2 24.4 (4.2) 11.8e37.9 23.6 (4.4) 12.7e37.7
Waist, cm 80.3 (9.9) 53e103 77.9 (9.8) 57e110
Hip, cm 94.8 (9.6) 64e122 92.3 (9.1) 72e119
Glucocorticoid use 32 (5.3%) 76 (22.4%)
Parent fractured hip 11 (2%) 14 (4.1%)
Previous fractures 86 (14.3%) 53 (15.6%)
Alcohol use 0 0
Current smoking 0 0
SD, standard deviation; BMI, body mass index.
Table 2
Pearson correlations (r) between anthropometric measures, bone mineral density/
speed of sound and T-scores.
Variable Hip FN Spine
BMD T-score BMD T-score BMD T-score
Age 0.47 0.43 0.46 0.41 0.22 0.20
Body weight 0.58 0.56 0.58 0.56 0.49 0.47
Height 0.25 0.21 0.30 0.27 0.22 0.20
BMI 0.51 0.50 0.49 0.48 0.43 0.42
SOS/T-score 0.45 0.41 0.45 0.40 0.42 0.38
Hip, total hip; FN, femoral neck; Spine, L1-L4; BMD, bonemineral density; BMI, body
mass index; SOS, speed of sound. P-values of all the associations were <0.001.
H.W.A.S. Subasinghe, S. Lekamwasam, P. Ball et al. Osteoporosis and Sarcopenia 6 (2020) 122e128The MLR analysis revealed that the 2 clinical risk factors; age
and body weight, either with or without QUS T score have a greater
ability to predict regional T-scores in postmenopausal women
(Table 3). The best model with the highest R2 value was selected to
predict the respective regional T-score.
Two osteoporosis risk assessment tools were devised (with and
without QUS data) based on the outcome of MLR analysis. Formulae
with E1 contained QUS data and formulae with E2 does not contain
QUS data.
1. Osteoporosis Risk Assessment Tool-1 (OPRAT-1) - Estimated
regional T-scores are denoted as T.Hip.E1, T.Spine.E1 and T.FN.E1
were calculated using below regression formulae.Table 3
Outcome of the multilinear regression analysis.


















QUS, quantitative ultrasound; FN, femoral neck.
a Indicate the models with best predictive ability.
124T.Hip.E1 ¼ 1.635 þ (0.029*age) þ (0.044*bodyweight)
þ (0.18*T_US)
T.FN.E1 ¼ 1.889 þ (0.028*age) þ (0.045*bodyweight)
þ (0.171*T_US)
T.Spine.E1 ¼ 6.203 þ (0.019*age) þ (0.052*bodyweight)
þ (0.287*T_US)
If at least one of these estimated T-score was  2.5, then the
patient was considered to have osteoporosis.
2. Osteoporosis Risk Assessment Tool 2 (OPRAT-2) - Estimated
regional T-scores are denoted as T.Hip.E2, T.Spine.E2 and T.FN.E2
were calculated using below regression formulae.
T.Hip.E2 ¼ 1.696 þ (0.038*age) þ (0.049*bodyweight).
T.FN.E2 ¼ 1.984þ (0.036*age) þ (0.050*bodyweight)
T.Spine.E2 ¼ 5.239 þ (0.01*age) þ (0.058*bodyweight)
If at least one of these estimated T-score was  2.5, then the
patient was considered to have osteoporosis.e model R2
Predictor variables
Constant þ Body weight 0.38
Constant þ Body weight þ US T-score 0.40
Constant þ Body weight þ US T-score þ age 0.44
Constant þ Body weight 0.33
Constant þ Body weight þ US T-score 0.41
Constant þ Body weight þ US T-score þ age 0.45
Constant þ Body weight 0.22
Constant þ Body weight þ US T-score 0.29
Constant þ Body weight þ US T-score þ age 0.31
Constant þ Body weight 0.31
Constant þ Body weight þ age 0.38
Constant þ Body weight 0.31
Constant þ Body weight þ age 0.39
Constant þ Body weight 0.22
Constant þ Body weight þ age 0.23
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Regional T-scores were estimated for all participants in the
validation sample using the formulae in OPRAT-1 and OPRAT-2.
Table 4 depicts mean comparisons between the actual and esti-
mated regional T-scores. Standard error of mean (SEM) of actual
and estimated T-scores are comparable in OPRAT-1 and OPRAT-2.
Bland-Altman plots were constructed to assess the agreement
between the estimated (by OPRAT-1 or OPRAT-2) and actual T-
scores of the validation sample (Figs. 1 and 2). In all plots, > 95% of
values were within the limits of agreement (mean of difference
±1.96 SD).
The prevalence of osteoporosis in the validation sample, esti-
mated based on the DXA derived T-score was 74.3%. This figure was
not statistically different (P < 0.001) from the estimations made by
the OPRAT-1 (75.4%) and OPRAT-2 (75.5%). The OSTA index revealed
32.4% were at high risk of osteoporosis while 34.5% were at inter-
mediate risk. The remaining study participants were at low risk of
osteoporosis.
The sensitivity of OPRAT-1 and OPRAT-2 were 83.2% and 82.5%,
respectively, while specificity remained at 44.8% in both tools.
Further, PPV and NPV of OPRAT-1 was 79.5% and 51%, respectively,
while the corresponding values were 81.2% and 47% in OPRAT-2,
respectively. The OSTA showed 76.2% sensitivity and 59.8% speci-
ficity. The PPV and NPV of OSTAwere 84.6% and 46.4%, respectively.
The similar standard error of estimate (SEE) and R2 values of
OPRAT-1 and OPRAT-2 depict their comparable predicting ability of
regional T-scores (Table 5).
4. Discussion
This study developed 2 osteoporosis risk assessing tools ie,
OPRAT-1 and OPRAT-2 which could predict regional T-scores of hip,
spine and FN of Sri Lankan postmenopausal women. Each tool
consisted of 3 formulae to estimate spine, hip and FN T-scores.
OPRAT-1 uses age, body weight and radial QUS T-score data to es-
timate regional T-scores. OPRAT-2 is a simpler tool and needs only
age and body weight to estimate T-scores. Therefore OPRAT-2 can
be easily used as a screening tool of high osteoporosis risk in
postmenopausal women. Numerous osteoporosis screening tools
have been developed and validated in other countries, regions or
ethnicities such as OSTA, ORAI, ORACLE and OSIRIS [7,9,19e21].
None of them has been validated for Sri Lankan population
previously.
OPRAT-1 and OPRAT-2 were developed using multilinear
regression analyses based on the hypothesis that clinical risk fac-
tors of osteoporosis could predict regional T-scores. In contrast,
most of currently available osteoporosis risk prediction tools have
been developed as scoring systems assigning a weigh for the clin-
ical risk factors used in the tool [7,9,16]. Age and body weight were
clinical risk factors considered as potential predictors of BMD T-Table 4
Comparison of actual and estimated T-scores in validation study sample.




OPRAT-1 T - Spine - T.Spine.E1 3.10 (1.35) 2.92 (
T - Hip - T.Hip.E1 1.48 (1.18) 1.59 (
T - FN - T.FN.E1 1.95 (1.18) 1.71(
OPRAT-2 T - Spine - T.Spine.E2 3.14 (1.38) 2.88 (
T - Hip - T.Hip.E2 1.46 (1.20) 1.59 (
T - FN - T.FN.E2 1.93 (1.16) 1.69 (
FN, femoral neck; OPRAT, Osteoporosis Risk Assessment Tool; SD, standard deviation; SE
This table shows mean (SD) comparison of actual and estimated regional T-scores. Pair
significant.
125scores and thus used in the final regression analyses to develop the
new tools. Advanced age and low body weight are well known
determinants of osteoporosis and fragility fractures [22e26]. Age
and body weight, together, contribute to bone mass greater than
other risk factors [23,25,26]. Therefore, these 2 factors have been
used in many osteoporosis risk prediction models either alone or in
combination with other clinical risk factors such as oestrogen use,
race, presence of rheumatoid arthritis, non-traumatic fractures,
current hormone replacement therapy, smoking, regular exercises,
and others [7,20]. OSTA uses only age and body weight to calculate
the osteoporosis risk [7]. Tools such as ORAI, SCORE, OSIRIS, and S~ao
Paulo Osteoporosis Risk Index (SAPORI) are using clinical risk fac-
tors other than age and body weight [9,19,20,27]. However, this
study did not reveal significant associations between parental
history of hip fractures, long-term glucocorticoid use, previous
history of fractures (after 45 years age), smoking or consumption of
alcohol, and regional T-scores.
Bone QUS is used to assess osteoporosis, although limitations
exist [28e31]. OPRAT-1 was developed on the assumption that QUS
data, when combined with other CRFs, would be a better predictor
of BMD based T-scores. We were unable to find previously devel-
oped osteoporosis risk prediction tools using QUS inputs.
The validation study proves that both OPRAT-1 and OPRAT-2
perform well as screening tools of osteoporosis. Both tools had
high and similar osteoporosis predicting ability. Further, both
OPRAT-1 and OPRAT-2 have comparable sensitivity performance
with OSTA. Sensitivity, specificity, NPV and PPV statistics of our
study are concordant with previously developed osteoporosis risk
assessment indices such as OST, ORAI, SCORE, KORAM, and OSIRIS
[7,9e12].
We used the T-score cut-off value of 2.5 in any of the skeletal
sites (femoral neck, hip, spine) described in the WHO guidelines to
diagnose osteoporosis in this study. Different cut-off values were
used in various osteoporosis risk assessing tools. The OST originally
used only the FN BMD T-Score  2.5 to identify osteoporosis [7]
but, Saravi later considered T-score  2.0 in FN, spine or total hip
in Argentinian postmenopausal women, and achieved a higher
sensitivity (83.7%) [32]. Similar to our analysis, the WHO criteria
have been used Su et al in Taiwan [8] and Reginster et al in France
[19] to diagnose osteoporosis.
We used 2 independent study samples, selected using the same
criteria for the development and validation of OPRAT-1 and OPRAT-
2. A study sample drawn from all 9 provinces of the country would
be more rational in developing country specific risk assessment
tools. But this could be a daunting task due to logistics and cost
considerations. The OST was built using 860 postmenopausal
women from 8 Asian countries [7], but contribution from an indi-
vidual country was lower than our study. Further, we used
community-dwelling women in this study to avoid selection bias,
though some studies did not include community samples. OSIRIS
was built on data from 1303 postmenopausal women selected fromted T-scores
SD)
Mean (SD) of difference SEM P-value
0.75) 0.18 (1.12) 0.08 0.021
0.77) 0.11 (0.91) 0.06 0.086
0.76) 0.24 (0.94) 0.06 <0.001
0.64) 0.26 (1.17) 0.06 <0.001
0.70) 0.12 (0.93) 0.05 0.014
0.70) 0.23 (0.92) 0.05 <0.001
M, standard error of mean. E1, estimated 1; E2, estimated 2.
ed t-test was performed for the analysis and P < 0.05 was considered statistically
Fig. 1. Bland-Altman plots of actual and OPRAT-1 estimated regional T-scores. 1a-actual T-spine and OPRAT-1 estimated T.spine.E1, 1b-actual T-Hip and OPRAT-1 estimated T.Hip.E.1,
1c-actual T-FN and OPRAT-1 estimated T.FN.E1.
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dated OSIRIS in 798 postmenopausal women referred by rheuma-
tologists at visits to routine check-ups or follow-ups [19].
There are a few limitations in this study. These formulae contain
only age and body weight, and the other clinical risk factors such as
previous fracture and parental history of hip fracture were not
considered due to low numbers. Both OPRAT-1 and 2 consist of 3
separate formulae to estimate T-scores of the hip, FN, and spine.
Hence all 3 calculations should be done to make a clinical decision.
This perhaps is time consuming and less user friendly. Furthermore,
the study participants were limited to 1 province and this may limit
the generalizability of the findings.
5. Conclusions
In conclusion, both OPRAT-1 and OPRAT-2 can be used as
screening tools to identify postmenopausal women with high risk
of osteoporosis. OPRAT-2 is more convenient and practical in any
setting as it uses only data of age and body weight. The OPRAT-1
requires radial QUS data, which is a major limitation.
To the best of our knowledge, these are the first osteoporosis
risk assessing tools developed for Sri Lankan postmenopausal
women using country specific data. This study suggests that
OPRAT-2 is a useful screening tool for osteoporosis to identify pa-
tients who need bone densitometry scanning. It can be used even in
a primary care setting or in general use as a self-screening tool.126Further, this is an affordable and simple tool that can be used with
basic resources. Therefore, it is a low-cost osteoporosis screening
method and would be advantageous to use in rural healthcare
centres of Sri Lanka where DXA facilities are not accessible. Finally,
facilitation of osteoporosis early identificationwill enable to initiate
preventive and therapeutic strategies aiming at reducing the health
and socioeconomic burden while improving quality of life of
postmenopausal women.Conflicts of interest
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Fig. 2. Bland-Altman plots of actual and OPRAT-2 estimated regional T-scores. 2a-actual T-spine and OPRAT-2 estimated T.spine.E2, 2b-actual T-Hip and OPRAT-2 estimated
T.Hip.E.2, 2c-actual T-FN and OPRAT-2 estimated T.FN.E2.
Table 5
Regression analyses comparing actual and estimated T-scores in the validation
sample.
Tool Variable r R2 SEE P-value
OPRAT-1 T.Hip.E1 0.63 0.40 0.92 <0.001
T.Spine.E1 0.56 0.31 1.12 <0.001
T.FN.E1 0.61 0.38 0.94 <0.001
OPRAT-2 T.Hip.E2 0.64 0.41 0.93 <0.001
T.Spine.E2 0.53 0.28 1.17 <0.001
T.FN.E2 0.61 0.37 0.92 <0.001
R2, coefficient of determination; r, correlation coefficient; SEE, standard error of the
estimate; OPRAT, osteoporosis risk assessing tool; FN, femoral neck. This table
shows the statistics of regression analysis that predicts the ability of new osteo-
porosis risk assessing tools to identify high risk patients.
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